arrow
Back
S

Shubham Pant

university of texas system

48H-index
588Paper Count
1.0WCitation Count
Published Papers 128
Publication Date
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials
errCancer
IF5.1
err2026-01-01
err0
errOAAI
errSaj, Fen; Namayanja, Felicity K.; Xiao, Lianchun; Borad, Mitesh J.; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S.; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W.; Fashoyin-aje, Lola A.; Javle, Milind
errShare
errSave
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
err2025-08-11
err0
errOAAI
errZev A. Wainberg; Colin D. Weekes; Muhammad Furqan; Pashtoon M. Kasi; Craig E. Devoe; Alexis D. Leal; Vincent Chung; James R. Perry; Thian Kheoh; Lisa K. McNeil; Esther Welkowsky; Peter C. DeMuth; Christopher M. Haqq; Shubham Pant; Eileen M. O’Reilly
errShare
errSave
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial
err2025-08-05
err0
errOAAI
errD. Melisi; T. Macarulla; C. De La Fouchardière; R.A. Pazo Cid; S.R. Chandana; I. Kiss; W.J. Lee; T.O. Goetze; E. Van Cutsem; A.S. Paulson; T. Bekaii-Saab; S. Pant; R.A. Hubner; F. Maxwell; L. Zhang; F. Benzaghou; E.M. O’Reilly; Z.A. Wainberg
errShare
errSave
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
err2025-04-17
err0
errOAAI
errYousef, Mahmoud; Yousef, Abdelrahman; Hurd, Mark W.; Pillai, Ashwathy; Chowdhury, Saikat; Snyder, Rebecca; Knafl, Mark; Lewis, Ryan L.; Roy, Paul M.; Fanaeian, Mohammad; Albarouki, Sali; Castelnovo, Luca F.; Peterson, Jennifer; Smaglo, Brandon G.; Wolff, Robert A.; Pant, Shubham; Willis, Jason; Huey, Ryan; Overman, Michael; Tzeng, Ching-Wei; Kim, Michael P.; Ikoma, Naruhiko; Maxwell, Jess E.; Katz, Matthew H. G.; Wang, Huamin; Maitra, Anirban; Koay, Eugene; Ludmir, Ethan B.; Chen, Anthony; Lopez, Camila; Ying, Haoqiang; Shen, John Paul; Zhao, Dan
errShare
errSave
ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year Experience
err2025-03-01
err0
PREAI
errJain, Anish J.; Lendoire, Mateo; Haddad, Antony; Tzeng, Ching-Wei D.; Boyev, Artem; Maki, Harufumi; Chun, Yun Shin; Arvide, Elsa M.; Lee, Sunyoung; Hu, Ian; Pant, Shubham; Javle, Milind; Cao, Hop S. Tran; Vauthey, Jean-Nicolas; Newhook, Timothy E.
errShare
errSave
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
err2025-03-01
err0
PREAI
errAhmed, Jibran; Knisely, Anne; Torrado, Carlos; Stephen, Bettzy; Yang, Yali; Song, Juhee; Alshawa, Anas; Zarifa, Abdulrazzak; Jhingran, Anuja; Koay, Eugene J.; Morris, Van Karlyle; Javle, Milind; Wolff, Robert A.; Meric-Bernstam, Funda; Pant, Shubham; Rodon, Jordi; Naing, Aung
errShare
errSave
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience
err2025-02-25
err1
PREAI
errJain, Anish J.; Lendoire, Mateo; Haddad, Antony; Tzeng, Ching-Wei D.; Boyev, Artem; Maki, Harufumi; Chun, Yun Shin; Arvide, Elsa M.; Lee, Sunyoung; Hu, Ian; Pant, Shubham; Javle, Milind; Tran Cao, Hop S.; Vauthey, Jean-Nicolas; Newhook, Timothy E.
errShare
errSave
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting
err2025-02-25
err0
errOAAI
errDemirdjian, Levon; Triantos, Spyros; Standish, Kristopher; Thomas, Shibu; Xia, Qi; Zhang, Jiarui; Greshock, Joel; Paone, Julie; Sheridan, Paige; Pant, Shubham; Massard, Christophe; Reardon, David A.; Loriot, Yohann; Schuler, Martin; Sweiti, Hussein
errShare
errSave
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study
err2024-11-08
err0
errOAAI
errBazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; Goel, Sanjay; Heist, Rebecca; Werner, Theresa L.; Eaton, Keith D.; Wang, Judy S.; Pant, Shubham; Adkins, Douglas R.; Blakely, Collin M.; Yan, Xiaohong; Neuteboom, Saskia; Christensen, James G.; Chao, Richard; Bauer, Todd
errShare
errSave
Quemliclustat (CD73 Inhibitor) reduces adenosine-regulated NR4A gene expression and increases mPDAC inflammation in patients from the ARC-8 trial
err2024-09-15
err0
PREAI
errKim, Ji Yun; Wang, Ning; Weeder, Ben; Stagnaro, Enzo; Mrouj, Karim; Aquino, Jose; He, Xian; O'Reilly, Eileen M.; Pant, Shubham; Manji, Gulam A.; Wainberg, Zev A.; Rhee, Joon; Beagle, Brandon; DiRenzo, Daniel; Walters, Matthew J.; Kaplan, Angelo; Cho, Sean; Kabbarah, Omar
errShare
errSave
Exploratory biomarker evaluation of the randomized Phase 2 cohort of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer
err2024-09-15
err0
PREAI
errMacarulla, Teresa; Cecchini, Michael; Garcia-Carbonero, Rocio; Golan, Talia; Perets, Ruth; Borazanci, Erkut; Pedegral, Manuel; Ponz-Sarvise, Mariano; Al Hallak, Mohammed Najeeb; Pant, Shubham; Boni, Valentina; Saavedra, Omar; Jose de Miguel-Luken, Maria; Leal, Alexis D.; Munoz Martin, Andres J.; Sauri-Nadal, Tamara; Schickler, Michael; Ben David, Hava; Reuveni, Hadas
errShare
errSave
A pilot study to assess the safety, tolerability, and tumor responses with lenvatinib plus pembrolizumab in patients with advanced pancreatic ductal adenocarcinoma in second-line or later of
err2024-09-15
err0
PREAI
errSmaglo, Brandon G.; Sun, Ryan; Pant, Shubham; Lee, Michael S.; Zhao, Dan; Le, Phat H.; Javle, Milind; Willis, Jason A.; Parseghian, Christine; Bhutani, Manoop; Chishty, Saman; Diao, Stacy; Leung, Michael W.; Huey, Ryan W.; Morelli, Maria Pia; Overman, Michael J.; Wolff, Robert A.
errShare
errSave
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer
err2024-08-21
err1
errOAAI
errPant, Shubham; Cho, Byoung Chul; Kyriakopoulos, Christos E.; Spira, Alexander; Tannir, Nizar; Werner, Theresa L.; Yan, Xiaohong; Neuteboom, Saskia; Chao, Richard; Goel, Sanjay
errShare
errSave
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
err2024-08-08
err1
errOAAI
errHarding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Lindsey, Stacie; Bachini, Melinda; Morement, Helen; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham
errShare
errSave
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
err2024-07-05
err7
PREAI
errDilly, Julien; Hoffman, Megan T.; Abbassi, Laleh; Li, Ziyue; Paradiso, Francesca; Parent, Brendan D.; Hennessey, Connor J.; Jordan, Alexander C.; Morgado, Micaela; Dasgupta, Shatavisha; Uribe, Giselle A.; Yang, Annan; Kapner, Kevin S.; Hambitzer, Felix P.; Qiang, Li; Feng, Hanrong; Geisberg, Jacob; Wang, Junning; Evans, Kyle E.; Lyu, Hengyu; Schalck, Aislyn; Feng, Ningping; Lopez, Anastasia M.; Bristow, Christopher A.; Kim, Michael P.; Rajapakshe, Kimal I.; Bahrambeigi, Vahid; Roth, Jennifer A.; Garg, Kavita; Guerrero, Paola A.; Stanger, Ben Z.; Cristea, Simona; Lowe, Scott W.; Baslan, Timour; Van Allen, Eliezer M.; Mancias, Joseph D.; Chan, Emily; Anderson, Abraham; Katlinskaya, Yuliya V.; Shalek, Alex K.; Hong, David S.; Pant, Shubham; Hallin, Jill; Anderes, Kenna; Olson, Peter; Heffernan, Timothy P.; Chugh, Seema; Christensen, James G.; Maitra, Anirban; Wolpin, Brian M.; Raghavan, Srivatsan; Nowak, Jonathan A.; Winter, Peter S.; Dougan, Stephanie K.; Aguirre, Andrew J.
errShare
errSave
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
errCANCER
IF5.1
err2024-06-14
err0
PREAI
errSaj, Fen; Wu, Y. Linda; Pant, Shubham; Goyal, Lipika
errShare
errSave
NALIRIFOX versus nab-paclitaxel and gemcitabine (Gem plus NabP) in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Subgroup analysis of patients aged 65 years or older in NAPOLI 3
err2024-06-01
err0
PREAI
errMacarulla Mercade, T.; Pazo Cid, R. A.; Womack, M.; Cubillo Gracian, A.; Zervoudakis, A.; Hatoum, H.; Chung, V.; Patel, A.; Paulson, A. S.; Pant, S.; O'Reilly, E. M.; Hubner, R.; Van Cutsem, E.; Bekaii-Saab, T.; Zhang, L.; Li, J.; Chen, H.; Maxwell, F.; Wainberg, Z. A.; Melisi, D.
errShare
errSave